| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Institut National de la Santé et de la Recherche Médicale U-344, Endocrinologie Moléculaire, Faculté de Médecine Necker, Paris, France;
Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, Sydney, Australia; and
Institut National de la Santé et de la Recherche Médicale U-429, Hopital Necker Enfants-Malades, Paris, France
Prolactin (PRL) is the primary lactogenic pituitary hormone that plays an essential role in many aspects of reproduction, from fertilization to mammary gland development and maternal behavior. PRL has also been reported to play a role in immunoregulation. Because initial observations indicated that hypophysectomized rats present abnormalities of the immune system, including increased thymic atrophy and lymphopenia, a number of studies have focused on the potential immunomodulatory roles of PRL. This hormone exerts its biological activities following binding to specific cell surface PRL receptors (PRLRs). In this report, we have characterized the development and function of the immune system in PRLR-deficient mice. Compared with wild-type control mice, PRLR-/- mice demonstrate no alterations in thymic or splenic cellularity or in the composition of the lymphocyte subsets present in primary (bone marrow and thymus) or secondary (spleen and lymph nodes) lymphoid organs. Lymphocytes from PRLR-/- mice are functional in vitro, as they can proliferate normally to mitogens, cytokines, and allogeneic cells. PRLR-/- splenocytes display normal NK-mediated cytotoxicity to YAC-1 target cells. In vivo studies have revealed that PRLR-/- mice are able to 1) generate normal steady-state Ig levels, 2) mount a normal specific Ig response following immunization with a T-dependent Ag, 3) eliminate injected allogeneic tumor cells, and 4) effectively control Listeria monocytogenes infection. Taken together, these results show that immune system development and function proceed normally in the absence of PRL-mediated signaling and suggest that PRLR pathways are not essential for immunomodulation in vivo.
This article has been cited by other articles:
|
|
 |
|
  S. Semprini, S. Friedrichsen, C. V. Harper, J. R. McNeilly, A. D. Adamson, D. G. Spiller, N. Kotelevtseva, G. Brooker, D. G. Brownstein, A. S. McNeilly, et al. Real-Time Visualization of Human Prolactin Alternate Promoter Usage in Vivo Using a Double-Transgenic Rat Model Mol. Endocrinol., April 1, 2009; 23(4): 529 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Huang, F. Snider, and J. C. Cross Prolactin Receptor Is Required for Normal Glucose Homeostasis and Modulation of {beta}-Cell Mass during Pregnancy Endocrinology, April 1, 2009; 150(4): 1618 - 1626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cohen-Solal, V Jeganathan, L Hill, D Kawabata, D Pinto-Rodriguez, C Grimaldi, and B Diamond Hormonal regulation of B-cell function and systemic lupus erythematosus Lupus, June 1, 2008; 17(6): 528 - 532. [Abstract] [PDF]
|
|
|
|
 |
|
 Z. Kang, G. Y. Bedecarrats, and D. Zadworny Expression Patterns of the Prolactin Receptor Gene in Chicken Lymphoid Tissues During Embryogenesis and Posthatch Period Poult. Sci., November 1, 2007; 86(11): 2404 - 2412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. LeBaron, T. J. Ahonen, M. T. Nevalainen, and H. Rui In Vivo Response-Based Identification of Direct Hormone Target Cell Populations Using High-Density Tissue Arrays Endocrinology, March 1, 2007; 148(3): 989 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Matsutani, T. S. A. Samy, L. W. Rue III, K. I. Bland, and I. H. Chaudry Transgenic prolactin-/- mice: effect of trauma-hemorrhage on splenocyte functions Am J Physiol Cell Physiol, May 1, 2005; 288(5): C1109 - C1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Dosiou and L. C. Giudice Natural Killer Cells in Pregnancy and Recurrent Pregnancy Loss: Endocrine and Immunologic Perspectives Endocr. Rev., February 1, 2005; 26(1): 44 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Horiguchi, S Yagi, K Ono, Y Nishiura, M Tanaka, M Ishida, and T Harigaya Prolactin gene expression in mouse spleen helper T cells J. Endocrinol., December 1, 2004; 183(3): 639 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Corbacho, G. Valacchi, L. Kubala, E. Olano-Martin, B. C. Schock, T. P. Kenny, and C. E. Cross Tissue-specific gene expression of prolactin receptor in the acute-phase response induced by lipopolysaccharides Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E750 - E757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fujikawa, H. Soya, K. L. K. Tamashiro, R. R. Sakai, B. S. McEwen, N. Nakai, M. Ogata, I. Suzuki, and K. Nakashima Prolactin Prevents Acute Stress-Induced Hypocalcemia and Ulcerogenesis by Acting in the Brain of Rat Endocrinology, April 1, 2004; 145(4): 2006 - 2013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Krishnan, O. Thellin, D. J. Buckley, N. D. Horseman, and A. R. Buckley Prolactin Suppresses Glucocorticoid-Induced Thymocyte Apoptosis in Vivo Endocrinology, May 1, 2003; 144(5): 2102 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zhou, F. R. A. Cagampang, J. A. Stirland, A. S. I. Loudon, and S. J. Hopkins Different Photoperiods Affect Proliferation of Lymphocytes but Not Expression of Cellular, Humoral, or Innate Immunity in Hamsters J Biol Rhythms, October 1, 2002; 17(5): 392 - 405. [Abstract] [PDF]
|
|
|
|
 |
|
 L.-Y. Yu-Lee Prolactin Modulation of Immune and Inflammatory Responses Recent Prog. Horm. Res., January 1, 2002; 57(1): 435 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Stevens, D W Ray, J Worthington, and J R. Davis Polymorphisms of the human prolactin gene--implications for production of lymphocyte prolactin and systemic lupus erythematosus Lupus, October 1, 2001; 10(10): 676 - 683. [Abstract] [PDF]
|
|
|
|
|
|
A R Buckley Prolactin, a lymphocyte growth and survival factor Lupus, October 1, 2001; 10(10): 684 - 690. [Abstract] [PDF]
|
|
|
|
|
|
L.-y. Yu-Lee Stimulation of interferon regulatory factor-1 by prolactin Lupus, October 1, 2001; 10(10): 691 - 699. [Abstract] [PDF]
|
|
|
|
|
|
L. Welniak, S. Richards, and W. Murphy Effects of prolactin on hematopoiesis Lupus, October 1, 2001; 10(10): 700 - 705. [Abstract] [PDF]
|
|
|
|
|
|
L Matera, M Mori, and A Galetto Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells Lupus, October 1, 2001; 10(10): 728 - 734. [Abstract] [PDF]
|
|
|
|
|
|
S E Walker Bromocriptine treatment of systemic lupus erythematosus Lupus, October 1, 2001; 10(10): 762 - 768. [Abstract] [PDF]
|
|
|
|
|
|
A. J. Craven, C. J. Ormandy, F. G. Robertson, R. J. Wilkins, P. A. Kelly, A. J. Nixon, and A. J. Pearson Prolactin Signaling Influences the Timing Mechanism of the Hair Follicle: Analysis of Hair Growth Cycles in Prolactin Receptor Knockout Mice Endocrinology, June 1, 2001; 142(6): 2533 - 2539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S E Walker Treatment of systemic lupus erythematosus with bromocriptine Lupus, March 1, 2001; 10(3): 197 - 202. [Abstract] [PDF]
|
|
|
|
 |
|
 K. A. McClellan, F. G. Robertson, J. Kindblom, H. Wennbo, J. Törnell, B. Bouchard, P. A. Kelly, and C. J. Ormandy Investigation of the Role of Prolactin in the Development and Function of the Lacrimal and Harderian Glands Using Genetically Modified Mice Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 23 - 30. [Abstract] [Full Text]
|
|
|
|
|
|
W. Savino and M. Dardenne Neuroendocrine Control of Thymus Physiology Endocr. Rev., August 1, 2000; 21(4): 412 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Dorshkind and N. D. Horseman The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency Endocr. Rev., June 1, 2000; 21(3): 292 - 312. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
